16 min listen
Bispecific Antibodies in the Management of Multiple Myeloma
Bispecific Antibodies in the Management of Multiple Myeloma
ratings:
Length:
42 minutes
Released:
May 24, 2024
Format:
Podcast episode
Description
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBispecificMM24).
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBispecificMM24).
Released:
May 24, 2024
Format:
Podcast episode
Titles in the series (100)
COVID-19 and Prostate Cancer: COVID-19 and prostate cancer treatment with Drs Neeraj Agarwal, Emmanuel S Antonarakis and A Oliver Sartor. by Oncology Today with Dr Neil Love